Estia Health downgrades guidance

Company News

by Rachael Jones

Aged care provider Estia Health (ASX:EHE) saw their NPAT for the half year to December 31 2018 up 4.1 per cent to $21.1 million.

Revenue is up 6.6 per cent to $289.7 million on the prior corresponding period.

EBITDA is also up 3.1 per cent to $46.9 million.

Despite these results Estia Health says it has revised its financial year 2019 guidance to a low to mid single digit percentage increase taking into account that costs arising from the royal commission are not reflected in the guidance.

A fully franked interim dividend of 8.0 cents per share has been declared.

Shares in Estia Health (ASX:EHE) are trading 1.87 per cent lower to $2.37.
 

Rachael Jones

Finance News Network
Rachael comes to FNN after working for Fairfax Media covering international breaking news, including the global economy and politics. She joined FNN in February 2018. She has reported on Australia’s finance news for various organisations since 2000 and has also interviewed a number of key business players, including Bill Gates. Rachael has also worked across a number of countries, including the UK and the US.